References
Moreira Neto F, Lourenco DM, Noguti MAE, Morelli VM, Gil ICP, Beltrao ACS, Figueiredo MS. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease. Braz J Med Biol Res. 2006;39(10):1291–5.
Houston PE, Rana S, Sekhsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in sickle cell disease: relationship to stroke. Am J Med. 1997;103:192–6.
Cattaneo M. Hyperhomocysteinaemia, atherosclerosis and thrombosis. Thromb Haemost. 1999;81:165–76.
Wright JG, Malia R, Cooper P, Thomas P, Preston FE, Serjeant GR. Protein C and protein S in homozygous sickle cell disease: Does hepatic dysfunction contribute to low levels? Br J Haematol. 1997;98:627–31.
Van der Dijs FPL, Schnog JJB, Brouwer DAJ, Velvis HJR, van den Berg GA, Bakker AJ, Duits AJ, Muskiet FD, Muskiet FAJ. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol. 1998;59:192–8.
Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. New Eng J Med. 1994;330:1639–44.
Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med. 2003;115(9):721–8.
Francis RB, Protein S Jr. Deficiency in sickle cell anemia. J Lab Clin Med. 1988;111(5):571–6.
Schnog JB, Mac Gillavry MR, van Zanten AP, Meijers JC, Rojer RA, Duits AJ, ten Cate H, Brandjes DP. Protein C and S and inflammation in sickle cell disease. Am J Hematol. 2004;76(1):26–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandey, S., Pandey, H.R., Mishra, R.M. et al. Increased Homocysteine Level in Indian Sickle Cell Anemia Patients. Ind J Clin Biochem 27, 103–104 (2012). https://doi.org/10.1007/s12291-011-0158-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-011-0158-7